Opko - M&A Summary and Business Overview

Life ScienceCompany

Opko M&A Summary

Opko has acquired 20 companies, including 1 in the last 5 years. It has also divested 3 assets.

Opko’s largest acquisition to date was in 2015, when it acquired Bio-Reference Laboratories for $1.5B. It’s largest disclosed sale occurred in 2021, when it sold OPKO Health - Sterile Fill & Finish Manufacturing Facility to Horizon Therapeutics Public Limited Company for $65M. Opko has acquired in 5 different US states, and 9 countries. The Company’s most targeted sectors include medical products (50%) and life science (45%).

Opko Business Overview

Where is Opko headquartered?

Opko is headquartered in Miami, Florida.

What is Opko’s revenue?

Opko disclosed revenue of 1,004M USD for 2022 and 1,775M USD for 2021.

How many employees does Opko have?

Opko has 5,269 employees.

What sector is Opko in?

Opko is a life science company.

When was Opko founded?

Opko was founded in 1991.

M&A Summary

  • M&A Total Activity23
    • M&A Buy Activity20
    • M&A Sell Activity3
  • Total Sectors Invested 3
  • Total Countries Invested 9
  • M&A Buy/Sell Connections 4
  • M&A Advisors 4

Opko

Opko Health, Inc.

4400 Biscayne Boulevard,
Miami, Florida 33137
United States,
(305) 575-4100
www.opko.com

Opko is a diversified healthcare company that seeks to establish industry-leading positions in large and rapidly growing medical markets. Opko's diagnostics business includes Bio-Reference Laboratories, a clinical laboratory with a core genetic testing business and a 420-person salesforce to drive growth and leverage new products, including the 4Kscore prostate cancer test and the Claros 1 in-office immunoassay platform. Opko's pharmaceutical business includes Rayaldee, a treatment for secondary hyperparathyroidism in patients with stage 3 or 4 chronic kidney disease and vitamin D insufficiency and VARUBI for chemotherapy-induced nausea and vomiting. Opko's pharmaceutical business also includes OPKO Biologics, which features hGH-CTP, a once-weekly human growth hormone injection and a longer acting Factor VIIa drug for hemophilia. Opko was founded in 1991 and is based in Miami, Florida.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # 19 - - 1 - - 20
vol $2.0B $300M $2.3B
Sell (0.2/yr) # 2 - 1 - - - 3
vol $65M $65M
  23

Most Recent M&A

Company Date Value Type
ModeX Therapeutics, Inc. 2022-05-09 300M USD Add-on Acquisition
Natick, Massachusetts · www.modextherapeutics.com
OPKO Health - Sterile Fill & Finish Manufacturing Facility 2021-06-17 65M USD Divestiture
Waterford, Ireland
CareEvolve 2017-02-17 - Divestiture
Elmwood Park, New Jersey · www.careevolve.com
Transition Therapeutics, Inc. 2016-06-30 60M USD Add-on Acquisition
Toronto, Ontario · www.transitiontherapeutics.com
Bio-Reference Laboratories, Inc. 2015-08-20 1.5B USD Add-on Acquisition
Elmwood Park, New Jersey · www.bioreference.com
EirGen Pharma Ltd. 2015-05-05 - Add-on Acquisition
Waterford, Ireland
Inspiro Medical Ltd. 2014-05-22 - Add-on Acquisition
Misgav, Israel · www.inspiromedical.com
Laboratorio Arama de Uruguay Limitada 2014-01-08 - Add-on Acquisition
Montevideo, Uruguay
PROLOR Biotech, Inc. 2013-08-29 480M USD Merger
Nes Ziyyona, Israel · www.prolor-biotech.com
Cytochroma, Inc. 2013-03-04 - Add-on Acquisition
Markham, Ontario · www.cytochroma.com
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Bio-Reference Laboratories, Inc. 2015-08-20 GeneDx, Inc. 2022-01-18 1
Elmwood Park, New Jersey · www.bioreference.com Gaithersburg, Maryland · www.genedx.com
Bio-Reference Laboratories, Inc. 2015-08-20 Roche Holding - U.S. Ariosa Centralized Laboratory Prenatal Testing Business 2021-08-16 1
Elmwood Park, New Jersey · www.bioreference.com Elmwood Park, New Jersey

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 9 (45%) 2.3B (99%) 2 (67%) 65M (100%)
Medical Products 10 (50%) 16M (1%) - -
Distribution 1 (5%) 4M (< 1%) - -
Internet Software and Services - - 1 (33%) -
Total 20 $2.3B 3 $65M

By Geo

State/Country Buy Value Sell Value
United States 7 1.8B 2 -
  Massachusetts 2 300M - -
  New Jersey 1 1.5B 1 -
  Tennessee 1 - - -
  Florida 1 - - -
Canada 3 60M - -
  Ontario 3 60M - -
Israel 3 480M - -
Chile 2 20M - -
Ireland 1 - 1 65M
Brazil 1 - - -
Mexico 1 - - -
Spain 1 - - -
Uruguay 1 - - -
Domestic 7 (35%) 1.8B (76%) 2 (67%) -
Cross-border 13 (65%) 560M (24%) 1 (33%) 65M (100%)
Total 20 $2.3B 3 $65M

Top M&A Advisors

Financial Deals
Barrington Research Associates, Inc.
1
J.P. Morgan Securities
1
Legal Deals
Akerman Senterfitt LLP
1
GreenbergTraurig
1

Deal Values

buy # Total
> $1B 1 $1.5B
$100M to $1B 2 $780M
< $100M 3 $80M
TOTAL $2.3B
Largest Bio-Reference Laboratories, Inc.
$1.5B (2015-08-20)
sell # Total
< $100M 1 $65M
TOTAL $65M
Largest OPKO Health - Sterile Fill & Finish Manufacturing Facility
$65M (2021-06-17)

M&A Connections

Deals
Acquired from
Strategic(s)
5%
1 (5%)
Divested to
Strategic(s)
100%
3 (100%)

 Subscribe to unlock this and 202,424
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.